AFFY has the peptide platform...even when co owned by J&J patents ... it must be worth at least a couple of millions of $$$
Hematide....this drug was almost approved. Just the cardiac risks had to be addresses and AFFY could address this because the cardiac risk was only in a sub group. So it is easy to not give the drug on this group.
That Hematide, when approved , will be a blockbuster is without any doubt. That is why J&J try to boycot it so badly.
Arlene her job is to talk with the J&J people and make a deal with them as soon as possible.
She should at least let the market know that she is in discussion with the J&J people !!!!
$170 million cash and receivables .... = $7/share ..... So at $5 we can buy this company for free....
Cash burn is around $5 million/quarter.
If you look at the graphics the last few days...the first 2 days was indeed selling....then the volume went down and then the Market Makers took over... They will try to let it down and down and down...very slowly ...so they can buy all your shares .... till nobody is selling anymore...and then the MM's will sell all there shares in a big upmove.
How do they do that? Very simple ; market makers sell and buy shares to eachother. So it is at NO COSTS AT ALL for them. So if 1 put a sell order , let say 10.000 at $4.8 , the other MM is making sure he buys those 10.000 shares.
So the bottom is there were no one is selling anymore. Where ever that may be